Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (221-230 of 334) with videos related to

Pageof 34
Sort By:
Pigment Cell & Melanoma Research|October 19, 2011
CSPG4, a potential therapeutic target, facilitates malignant progression of melanomaMatthew A Price, Leah E Colvin Wanshura, Jianbo Yang, et al.
Journal for Immunotherapy of Cancer|March 12, 2022
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancerTheodoros Michelakos, Filippos Kontos, Tomohiro Kurokawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non-Small Cell Lung CancerIla J Datar, Sacha C Hauc, Shruti Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2013
LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastomaJacky T Yeung, Ronald L Hamilton, Koji Ohnishi, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2008
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodiesAllison S Drake, Michael T Brady, Xin Hui Wang, et al.
Frontiers in Immunology|May 13, 2017
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical RelevanceSara Caratelli, Tommaso Sconocchia, Roberto Arriga, et al.
BMC Cancer|February 24, 2007
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expressionJan Willem F Dierssen, Noel F C C de Miranda, Soldano Ferrone, et al.
Cell Communication and Signaling : CCS|March 7, 2020
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiramTing Sun, Wei Yang, Sneh M Toprani, et al.
Cell Communication and Signaling : CCS|April 4, 2020
Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiramTing Sun, Wei Yang, Sneh M Toprani, et al.
European Journal of Immunology|November 14, 2015
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitorsRosa Sottile, Pradeepa N Pangigadde, Thomas Tan, et al.
Pageof 34

Showing results (221-230 of 334) with videos related to

Sort By:
Pageof 34
Pigment Cell & Melanoma Research|October 19, 2011
CSPG4, a potential therapeutic target, facilitates malignant progression of melanomaMatthew A Price, Leah E Colvin Wanshura, Jianbo Yang, et al.
Journal for Immunotherapy of Cancer|March 12, 2022
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancerTheodoros Michelakos, Filippos Kontos, Tomohiro Kurokawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non-Small Cell Lung CancerIla J Datar, Sacha C Hauc, Shruti Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2013
LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastomaJacky T Yeung, Ronald L Hamilton, Koji Ohnishi, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2008
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodiesAllison S Drake, Michael T Brady, Xin Hui Wang, et al.
Frontiers in Immunology|May 13, 2017
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical RelevanceSara Caratelli, Tommaso Sconocchia, Roberto Arriga, et al.
BMC Cancer|February 24, 2007
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expressionJan Willem F Dierssen, Noel F C C de Miranda, Soldano Ferrone, et al.
Cell Communication and Signaling : CCS|March 7, 2020
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiramTing Sun, Wei Yang, Sneh M Toprani, et al.
Cell Communication and Signaling : CCS|April 4, 2020
Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiramTing Sun, Wei Yang, Sneh M Toprani, et al.
European Journal of Immunology|November 14, 2015
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitorsRosa Sottile, Pradeepa N Pangigadde, Thomas Tan, et al.
Pageof 34